Ascletis' NDA for Its All-oral HCV Treatment Accepted by CFDA

Written by ACN Newswire

Wednesday, 1 August 2018, 18:35 HKT/SGT

Hangzhou and Shaoxing, China , Aug 1, 2018 - (ACN Newswire) - Ascletis announced today it has received the acceptance letter from the China Food and Drug Administration (CFDA) for Ravidasvir (RDV) new drug application (NDA). Ravidasvir in combination with Ganovo (RDV/DNV Regimen) is the first all-oral interferon-free HCV regimen developed by a domestic company in China. Phase II/III clinical trial has shown that RDV/DNV Regimen demonstrated a cure rate of 99 % ( SVR12) with a short treatment duration of 12 weeks in genotype 1 patients. In patients with baseline NS5A resistance mutations, RDV/DNV Regimen demonstrated a cure rate of 100% (SVR12).

"Ascletis was successfully listed this morning on Hong Kong Exchange as the first ever pre-revenue biotech. The NDA for our all-oral HCV regimen was accepted by CFDA in the afternoon." Jinzi J. Wu, Ph.D., Ascletis' founder, President and CEO, commented, "Two significant accomplishments on the same day reflect our unremitting effort to provide affordable and effective HCV cures to the patients and to fulfill our commitment to the investors."

Ganovo Regimen, Ascletis' first breakthrough HCV regimen, was approved on June 8 and launched on June 27, 19 days after the approval. The acceptance of the NDA for its all-oral HCV regimen enables Ascletis soon to provide two HCV treatment options for Chinese patients, strengthening its leading position in China's HCV field.

Topic: Press release summarySectors: Daily Finance, Daily News, BioTech ^[1]^[2]^[3] http://www.acnnewswire.com From the Asia Corporate News Network

References

^{^} Daily Finance (www.acnnewswire.com)
^{^} Daily News (www.acnnewswire.com)
^{^} BioTech (www.acnnewswire.com)

Ascletis' NDA for Its All-oral HCV Treatment Accepted by CFDA

References

How to Choose the Right Business Networking Event in Brisbane for You

Victoria’s planning reforms could help solve the housing crisis. But they are under threat

A looming workforce crisis in NZ tourism and hospitality threatens industry growth plans

Free food and beer are common perks for hospitality workers – but are they masking unfairness?

How Proper Training Leads to Increased Profits

Ever wanted to ditch the 9-to-5 and teach snowsports? We followed people who did it for 10 years

Traditions of Rural Bali at Villa Sabana

How Sydney Drone Photography Transforms the Way Properties Are Marketed

Research suggests those who use buy-now-pay-later services end up spending more

Tips on How to Create a Perfect Logo for Your Business

How To Help Your Restaurant Run More Smoothly

UNSW startup accelerator offers $200K to the next generation of Australian deeptech unicorns

The Future Is Now: AI Modernization Is Reshaping How Business Gets Done

Businesses losing an average of $493k from data integrity flaws

AI shopping disruptor Zyft raises $7.5M to lead the next gen of retail tech

Little known law offers savvy Kiwis the opportunity to supercharge their retirement savings

Cutting edge AI technology designed for doctors to reduce patient wait times launched in NZ